Choosing an MS treatment is one of the hardest conversations people have with their care team, and it is made harder by unfamiliar vocabulary — disease-modifying therapies, high-efficacy versus escalation approaches, infusions versus pills. These terms describe the overall strategy, not brand-name drugs. Knowing them makes treatment conversations and trade-offs easier to follow.
It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.